Healthium Medtech Acquires Controlling Stake in Paramount Surgimed

The combination is expected to create operational and commercial synergies by pairing Paramount's manufacturing scale and regulatory approvals-including EU MDR and USFDA certifications, with Healthium's distribution strength and market access.

Healthium Medtech has signed an accord to acquire a controlling stake in Paramount Surgimed, one of the leading Indian manufacturers and exporters of surgical blades and scalpels, as it scales its global presence in high-precision surgical consumables.

The transaction has been structured towards sharpening Healthium's focus on precision surgical products while strengthening India's medical device manufacturing ecosystem.

Founded over three decades ago, Paramount Surgimed has established itself as one of India’s largest producers of surgical blades, scalpels and dermal biopsy devices.

And, Healthium will seek to deliver a wider range of clinical needs with an integrated product portfolio, with the addition of Paramount's offerings in blades and dermal biopsy.

Under the transaction terms, Paramount's non-surgical businesses will be separated pre-completion and retained by the promoter, the Grover family, inclusive of its lifestyle and hygiene segments.

Financial details of the controlling stake being acquired by Healthium were not shared.

Commenting on the transaction, Anish Bafna, CEO and Managing Director, Healthium Medtech, said the acquisition is in tune with the company's long-term strategy. "The acquisition fortifies the strategy of scaling its global surgical consumables business through high-precision technologies," he said.

He added that Paramount's track record in quality and manufacturing excellence fits closely with Healthium's vision, with a strong emphasis on seamless integration, customer trust and supply reliability.

According to a statement, Paramount Surgimed Managing Director Shaily Grover said the partnership marks an important milestone in the evolution of the company. She added that Healthium's operational competencies and international reach would support the next phase of growth for Paramount's surgical disposables business, while strengthening the brand and improving customer reliability across markets.

The combination is expected to create operational and commercial synergies by pairing Paramount's manufacturing scale and regulatory approvals-including EU MDR and USFDA certifications, with Healthium's distribution strength and market access.

The companies also see opportunities for shared research and development and the introduction of differentiated, high-precision products over time.

Stay tuned for more such updates on Digital Health News